High-density lipoprotein cholesterol and triglycerides as therapeutic targets for preventing and treating coronary artery disease
- 1 December 2002
- journal article
- review article
- Published by Elsevier in American Heart Journal
- Vol. 144 (6) , S33-S42
- https://doi.org/10.1067/mhj.2002.130301
Abstract
No abstract availableKeywords
This publication has 63 references indexed in Scilit:
- Paraoxonase 1 Overexpression in Mice and Its Effect on High-Density LipoproteinsBiochemical and Biophysical Research Communications, 2002
- Statin-induced inhibition of the Rho-signaling pathway activates PPARα and induces HDL apoA-IJournal of Clinical Investigation, 2001
- Executive Summary of the Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III)JAMA, 2001
- Acute-Phase Proteins and Other Systemic Responses to InflammationNew England Journal of Medicine, 1999
- Hypertriglyceridemia and elevated lipoprotein (a) are risk factors for major coronary events in middle-aged menThe American Journal of Cardiology, 1996
- Plasma Triglyceride Level and Mortality from Coronary Heart DiseaseNew England Journal of Medicine, 1993
- High-Density Lipoprotein — The Clinical Implications of Recent StudiesNew England Journal of Medicine, 1989
- Influence of serum amyloid A on cholesterol esterification in human plasmaBiochimica et Biophysica Acta (BBA) - Lipids and Lipid Metabolism, 1989
- Helsinki Heart Study: Primary-Prevention Trial with Gemfibrozil in Middle-Aged Men with DyslipidemiaNew England Journal of Medicine, 1987
- The triglyceride issue: A view from FraminghamAmerican Heart Journal, 1986